Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Harris

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Prostaglandins|August 1, 1992
DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptorsE C Liu, A Hedberg, H J Goldenberg, et al.
Journal of Medicinal Chemistry|May 1, 1989
9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonistsS E Hall, W C Han, D N Harris, et al.
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
Effect of SQ 80,338 (1-(3-phenyl-2-propenyl)-1H-imidazole) on thromboxane synthetase activity and arachidonic acid-induced platelet aggregation and bronchoconstrictionD N Harris, R Greenberg, M B Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human plateletsA Hedberg, S E Hall, M L Ogletree, et al.
British Heart Journal|December 1, 1981
Pulmonary perfusion imaging applied to prediction of pulmonary vascular pressures in mitral and aortic valve diseaseD N Harris, D N Taylor, K S Rao, et al.
Journal of Cyclic Nucleotide Research|January 1, 1979
Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivativesD N Harris, M M Asaad, M B Phillips, et al.
The American Journal of Physiology|March 1, 1989
Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeysW A Schumacher, C L Heran, H J Goldenberg, et al.
Journal of Medicinal Chemistry|November 1, 1986
9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenaseS E Hall, W C Han, M F Haslanger, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonistM L Ogletree, D N Harris, W A Schumacher, et al.
Biochemical Pharmacology|January 15, 1973
Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesteraseD N Harris, M Chasin, M B Phillips, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Prostaglandins|August 1, 1992
DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptorsE C Liu, A Hedberg, H J Goldenberg, et al.
Journal of Medicinal Chemistry|May 1, 1989
9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonistsS E Hall, W C Han, D N Harris, et al.
Advances in Prostaglandin and Thromboxane Research|January 1, 1980
Effect of SQ 80,338 (1-(3-phenyl-2-propenyl)-1H-imidazole) on thromboxane synthetase activity and arachidonic acid-induced platelet aggregation and bronchoconstrictionD N Harris, R Greenberg, M B Phillips, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human plateletsA Hedberg, S E Hall, M L Ogletree, et al.
British Heart Journal|December 1, 1981
Pulmonary perfusion imaging applied to prediction of pulmonary vascular pressures in mitral and aortic valve diseaseD N Harris, D N Taylor, K S Rao, et al.
Journal of Cyclic Nucleotide Research|January 1, 1979
Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivativesD N Harris, M M Asaad, M B Phillips, et al.
The American Journal of Physiology|March 1, 1989
Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeysW A Schumacher, C L Heran, H J Goldenberg, et al.
Journal of Medicinal Chemistry|November 1, 1986
9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenaseS E Hall, W C Han, M F Haslanger, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonistM L Ogletree, D N Harris, W A Schumacher, et al.
Biochemical Pharmacology|January 15, 1973
Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesteraseD N Harris, M Chasin, M B Phillips, et al.
Pageof 7